Atlas Trials

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT05634954 · WITHDRAWN

Trial details

NCT number
NCT05634954
Sponsor
GE Healthcare
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-02-01
Primary completion
2026-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.